Skip to content
Gold Mining News – Lifestyle
Home
Sample Page
Author:
Elanco Animal Health
New Research Reveals Pet Spending as a “Protected Budget Item” for Owners, Fueling Industry Resilience
June 3, 2026
Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market
May 18, 2026
Elanco to Participate in Upcoming Investor Conferences
May 14, 2026
Elanco Animal Health Reports First Quarter 2026 Results
May 6, 2026
/C O R R E C T I O N — Elanco Animal Health/
April 28, 2026
Elanco’s Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock
April 27, 2026
Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement
April 16, 2026
Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*
April 9, 2026